Sunlit Uplands: The Genius of the NICE Reference Case
The NICE reference case has received widespread acceptance in health technology assessment. The lifetime cost-per-QALY model and constructed claims for product impact have been widely emulated in country-specific guidelines for formulary submission as well as in publications in the leading health te...
Main Author: | Paul C Langley |
---|---|
Format: | Article |
Language: | English |
Published: |
University of Minnesota Libraries Publishing
2016-07-01
|
Series: | INNOVATIONS in Pharmacy |
Subjects: | |
Online Access: | https://pubs.lib.umn.edu/index.php/innovations/article/view/435 |
Similar Items
-
HAS Should Not Be NICE: Rejecting Imaginary Worlds in the French Technology Assessment Guidelines
by: Paul C Langley
Published: (2017-01-01) -
He Ao Pohewa: The PHARMAC Prescription for Pharmacoeconomic Analysis in New Zealand and the Standards of Normal Science
by: Paul C Langley
Published: (2016-07-01) -
Imaginary Worlds: A Systematic Review of the Status of Modeled Cost-Effectiveness Claims Published in the Journal of Medical Economics from January 2015 to December 2015
by: Paul C Langley, et al.
Published: (2016-07-01) -
Supporting Formulary Decisions: The Discovery of New Facts or Constructed Evidence?
by: Paul C Langley
Published: (2016-07-01) -
Imaginary Worlds: Modeled claims for cost-effectiveness published in PharmacoEconomics January 2015 to December 2015
by: Paul C Langley
Published: (2016-07-01)